{{Rsnum
|rsid=2547917
|Gene=PDE4D
|Chromosome=5
|position=59417854
|Orientation=plus
|GMAF=0.174
|Gene_s=PDE4D
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.1 | 32.3 | 64.6
| HCB | 2.2 | 31.1 | 66.7
| JPT | 7.0 | 39.5 | 53.5
| YRI | 3.2 | 25.4 | 71.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 31.1 | 66.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=3E-6
  |OR=2.00
  |ORtxt=[1.345-2.965]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}